Avecho Biotechnology Ltd
ASX:AVE

Watchlist Manager
Avecho Biotechnology Ltd Logo
Avecho Biotechnology Ltd
ASX:AVE
Watchlist
Price: 0.01 AUD 11.11% Market Closed
Market Cap: 36.7m AUD

Net Margin
Avecho Biotechnology Ltd

-262.4%
Current
-449%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-262.4%
=
Net Income
-3.6m
/
Revenue
1.4m

Net Margin Across Competitors

No Stocks Found

Avecho Biotechnology Ltd
Glance View

Market Cap
36.7m AUD
Industry
Pharmaceuticals

Avecho Biotechnology Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. The company is headquartered in Melbourne, Victoria. The firm's products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, Dairy TPM, and Veterinary Applications. The firm's segments include Production and Personal Care and Human Health. The Production and Personal Care segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches. The Human Health segment focuses on the development of patches, including TPM/Oxymorphone, TPM/enhanced, and TPM/Oxycodone. Its TPM products are commercialized under license Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

AVE Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-262.4%
=
Net Income
-3.6m
/
Revenue
1.4m
What is the Net Margin of Avecho Biotechnology Ltd?

Based on Avecho Biotechnology Ltd's most recent financial statements, the company has Net Margin of -262.4%.

Back to Top